Tuesday, 5 November 2019
Meeting category
Date(s)
5 Nov 2019
Location
Basel,
Switzerland
Organizer
European HIV Clinical Forum 2019
Related Enduring Materials
Enduring Materials
Preliminary Program
Opening session - 9:00
9:00 CET
Welcome, Introductions and Goals
Jonathan Schapiro, MD
National Hemophilia Center Sheba Medical Center, Israel
Marcel Stöckle, MD
University Hospital Basel, Switzerland
Session 1: Position of INSTIs in clinical management of PLWH - 09:15
09:15 CET
First line regimens in different European countries 2019 – an overview
09:40 CET
Second generation INSTI regimens for drug naive patients: State of the Art
10:05 CET
Abstract - Longitudinal trends in self-reported side effects and prescribed 3rd agent in ART
Gaetano Marrone
Department Of Infectious Disease, Karolinska Hospital, Stockholm
Session 2: Treatment and Prevention: State of the Art - 15:55
15:55 CET
When to start antiretroviral therapy after diagnosis – trade-offs and considerations
11:40 CET
Round table on PrEP: Challenges of long-term PrEP
12:00 CET
Round table on PrEP: Oral versus injectable PrEP
Session 3: Novel treatment options - 13:45
13:45 CET
Impact on children and adolescence
14:10 CET
Long acting parenteral antiretroviral regimens - where might they fit?
14:35 CET
Single tablet regimens versus multiple pills – is there a meaningful difference?
15:00 CET
Abstract - HIV and Ageing - Primary and secondary prevention of coronary artery disease among People living with HIV
Gaetano Marrone
Karolinska Hospital, Stockholm
Session 4: Round table on long-term ramifications of expanded global first line second-generation INSTI use - 15:50
15:50 CET
Impact on transmitted and acquired drug resistance
16:05 CET
Impact on women’s health & weight gain
16:20 CET
Impact on children and adolescence
17:15 CET
Closing Remarks
Overview
Welcome
We would like to thank everyone that joined the European HIV Clinical Forum 2019: Optimizing Treatment. Your excellent questions contributed to the great discussions and ultimate success of this meeting. We would also like to thank our speakers for giving their amazing lectures. We would like to encourage you and your colleagues to plan submitting your upcoming research results to the next edition of the meeting.
On behalf of the European HIV Clinical Forum 2019 Program Chairs, we would like to thank ViiV Healthcare for their unrestricted educational grant and Gilead Sciences for their Gold-level sponsorship. We would also like to thank our endorsers for their invaluable support of the meeting.
We look forward to welcoming you again to our future meetings!
The Program Chairs
Program Chairs 2019
Jonathan Schapiro, MD
National Hemophilia Center Sheba Medical Center, Israel
Charles Boucher MD, PhD
Medical Center, The Netherlands
Local Chair
Marcel Stöckle, MD
University Hospital Basel, Switzerland
General Information
Meeting Objectives
With the HIV Clinical Forum program we aim to:
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment options
- Translate the latest research achievements into clinical guidance for the optimal management of HIV-positive individuals
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment options
- Translate the latest research achievements into clinical guidance for the optimal management of HIV-positive individuals
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:
- Understand the clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might best benefit from long acting injectable regimens
- Know how best to integrate injectable drugs in to routine clinical care
- Understand the clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might best benefit from long acting injectable regimens
- Know how best to integrate injectable drugs in to routine clinical care
Committees
Program Chairs 2019
Jonathan Schapiro, MD
National Hemophilia Center Sheba Medical Center, Israel
Charles Boucher, MD, PhD
Erasmus Medical Center, the Netherlands
Local Chair
Marcel Stöckle, MD
University Hospital Basel, Switzerland
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Support
Support
Endorsers
Language
